Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Arcus Biosciences (RCUS) Long-Term Debt Issuances (2024)

Arcus Biosciences has reported Long-Term Debt Issuances over the past 1 years, most recently at $47.0 million for Q3 2024.

  • Quarterly results put Long-Term Debt Issuances at $47.0 million for Q3 2024, changed N/A from a year ago — trailing twelve months through Dec 2025 was $47.0 million (changed N/A YoY), and the annual figure for FY2025 was $49.0 million, up 4.26%.
  • Long-Term Debt Issuances for Q3 2024 was $47.0 million at Arcus Biosciences.
  • Over the last five years, Long-Term Debt Issuances for RCUS hit a ceiling of $47.0 million in Q3 2024 and a floor of $47.0 million in Q3 2024.